Colon Cancer Screening Laws Now Cover Half of U.S. Population
Five States Passed Laws in 2007, but 26 Still Earn D's or F's on Legislation Report Card WASHINGTON, March 11 /PRNewswire-USNewswire/ -- For the first time, more than half of the U.S. population is now covered by state laws that require insurance providers to cover t...Research by Case Western Reserve University, VA earns cover of prestigious science publication
CLEVELAND An interdisciplinary team from the department of macromolecular science and engineering at Case Western Reserve University, the Louis Stokes Cleveland VA Medical Center and the NASA Glenn Research Center earned the December 2007 cover of Nature Nanotechnology, one of the worlds most pre...Professor Strauf's research is Nature Photonics cover article
HOBOKEN, N.J. Stefan Strauf, Assistant Professor in the Department of Physics & Engineering Physics at Stevens Institute of Technology, along with colleagues from the University of California, Santa Barbara and Leiden University (Netherlands), has authored the article, High-frequency single-photon...New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine
FORT LAUDERDALE, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser optical breast cancer imaging systems, announced that its CT Laser Mammography (CTLM(R)) system, designed as an adjunct to x-ray systems to detect breast can...KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...ith the SEC on April 30, 2009, as well as certain other of the Company's SEC filings; (23) the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability or securities litigation; (24) the informal inquiry initi...Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
...he U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/694,260, titled "Cyclic Natriuretic Peptide Constructs." Allowed claims cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate. Palat...IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods
...ply appreciate the credence the EPA's leadership gives to in vitro methods and hope that this will lead to EPA guidelines that will more permanently cover this type of approach." The goal of the EPA's pilot program is to evaluate the effectiveness of a non-animal testing method to replace the cur...Micromet Announces Pricing of Public Offering of Common Stock
...s expected to take place on August 4, 2009. The underwriters have a 30-day option to purchase up to an additional 2,100,000 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. is acting as the sole book running manager with RBC Capital Markets and Merriman Curhan Ford as co-m...Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
... is significantly influencing current decision making with respect to oncology drug development. With this in mind, Dr. Bergstein's presentation will cover novel pre-clinical and clinical development paradigms, including human trial design, of drug candidates that target cancer stem cells. The talk will ...Cell Therapeutics, Inc. Announces Exercise of Overallotment
...s option to purchase 4,399,816 additional shares of its common stock and warrants to purchase up to 1,099,954 additional shares of its common stock to cover overallotments. The exercise of the underwriter's overallotment option results in the issuance in this offering of an aggregate of 33,731,923 shares ...Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
...on to purchase up to 4,399,816 additional shares of its common stock and warrants to purchase up to 1,099,954 additional shares of its common stock to cover overallotments, if any. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses, exclu...Material world: Graphene's versatility promises new applications
...f the material has proven trickier. Graphene is remarkable in terms of thinness and resiliency. A one-atom thick graphene sheet sufficient in size to cover a football field, would weigh less than a gram. It is also the strongest material in natureroughly 200 times the strength of steel. Most of the excite...Unexpectedly long-range effects in advanced magnetic devices
...imum practical size for the magnetic islands that record data on hard disk drives, according to NIST metallurgist Robert Shull. The key trick is to cover a thin layer of a ferromagnetic material, in which the magnetic direction of electrons, or "spins," tend to order themselves in the same direction, wi...Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
...re does not require hospitalization or complicated surgery and typically takes less than an hour. Most health-insurance policies cover varicose vein treatment. To learn more about varicose veins or available treatment options, please visit www.veinclinics.com or call 866-617-VEIN. ...Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
...ric with crush resistant channels increasing air circulation and flow beneath the patient. In turn, the high moisture vapor permeable, stain resistant cover improves the ability to manage heat and moisture directly beneath the patient. The product also offers PressureSmart(TM) Sensing Technology that sense...EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
... development of our organization," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "The EUCODIS Bioscience team has demonstrated its capacity to cover the whole value-chain of an integrated enzyme supplier, from enzyme development, to manufacturing, and to marketing. This success adds momentum to our...SPO Medical Expands Professional Product Offering
...sident and Chief Executive Officer of SPO Medical commented: "By expanding our sensor offerings with the hand-held PulseOx 6100(TM) we are now able to cover a broader range of adult and pediatric patient population. The new sensor has been designed to be soft and comfortable with an ergonomic thimble to en...Medivation Announces Pricing of Public Offering
...ese shares on or about June 2, 2009. The company has granted the underwriters a 30-day option to purchase 412,500 additional shares of common stock to cover over-allotments, if any. J.P. Morgan Securities Inc. is acting as sole book-running manager of the offering. The company currently expects ...Beckman Coulter, Inc. Announces Pricing of Common Stock Offering
...ve granted the underwriters of the common stock offering an option to purchase up to an additional 450,000 shares of Beckman Coulter's common stock to cover over-allotments; provided that Beckman Coulter may elect, in its sole discretion, in lieu of having the forward purchasers grant such option to the un...PharmAthene Reports First Quarter 2009 Financial and Operational Results
...h the National Institute of Allergy and Infectious Diseases (NIAID). The scope of work under the BARDA contract, which took effect April 1, 2009, will cover ongoing stability studies, development of potency assays, as well as certain manufacturing technology transfer and scale-up activities for SparVax(TM)...Dendreon Announces Common Stock Offering
...ole manager for the offering. Dendreon has granted Deutsche Bank Securities an option to purchase an additional 1,279,166 shares of common stock to cover over-allotments, if any. Dendreon intends to use the net proceeds of the offering to develop manufacturing facilities, a distribution network, ...ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
... channel and GPCR services (both automated high-throughput and GLP), cell lines, differentiated human stem cells, membranes, and related products that cover nearly half of the known drugable genome, along with cell line construction and scale-up, membrane preparation, and large-scale cryopreservation of ce...Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
...1, 2009, the Company had cash and investments in the amount of $2,677,581, and working capital of $2,594,256. Senesco estimates that such amount will cover its expenses for approximately the next four months from March 31, 2009. About Senesco Technologies, Inc. Senesco Technologies, Inc. is a ...CryoLife Reports Record First Quarter Revenues of $26.7 Million
...hysicians have been and may be reluctant to implant or use our preserved tissues or products, our existing insurance policies may not be sufficient to cover our actual claims liability, current economic conditions may impact demand for our tissues and products, intense competition may affect our ability to...Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009
...he first quarter, the company decided to reduce the outstanding foreign exchange contracts. The remaining foreign exchange contracts of USD 46 million cover the expected USD income from the RFP-3 contract in 2009. The reduction in the outstanding foreign exchange contracts has been executed in order to eli...The Biotechnology Industry Organization Honors Georgia Governor Sonny Perdue as Governor of the Year
...mate change and biofuels. In addition, this year's BIO Exhibition will cover will cover an estimated 200,000 net sq. ft. and host more than 2,000 exhibitors. ...